Artisan Partners Limited Partnership Adds $211M in ICON Public Limited Company ($ICLR)
Key Points
- Artisan Partners Limited Partnership changed its ICON Public Limited Company ($ICLR) stake by 20.4% last quarter, boosting to 8,278,945 shares worth $1.24 billion.
- Wall Street's consensus rating on $ICLR is Buy and an average price target of $153.25.
- $ICLR last traded around $149.92.
Artisan Partners Limited Partnership increased its position in ICON Public Limited Company ($ICLR) by 20.4% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,278,945 shares of ICON Public Limited Company after buying 1,404,968 shares during the quarter. Artisan Partners Limited Partnership's holdings in ICON Public Limited Company were worth $1.24 billion as of its most recent filing.
ICON Public Limited Company ($ICLR) Stock
ICON Public Limited Company Earnings
Analysts Set New Price Targets
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.